trial · primary record
Atezolizumab
Colon Adenocarcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 712 |
| Primary completion | 2026-12-18 |
| Primary endpoint | Disease Free Survival (DFS) |
| Registry ID | NCT02912559 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:56.737Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02912559
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.